Resultados de procura - Josep M. Piulats

Limitar resultados
  1. 1
    Uveal melanoma as a target for immune-therapy

    Uveal melanoma as a target for immune-therapy por Marc Oliva, Antonio Rullan, Josep M. Piulats

    Publicado 2016
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Facts and Hopes in Immunotherapy of Endometrial Cancer

    Facts and Hopes in Immunotherapy of Endometrial Cancer por Juan A. Marín‐Jiménez, Sandra García‐Mulero, Xavier Matías‐Guiu, Josep M. Piulats

    Publicado 2022
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?

    Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope? por Florian Castet, Sandra García‐Mulero, Rebeca Sanz‐Pamplona, A. Cuéllar, Oriol Casanovas, J. Maria Caminal Mitjana, Josep M. Piulats

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations

    A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations por David Tamborero, Carlota Rubio-Pérez, Ferran Muiños, Radhakrishnan Sabarinathan, Josep M. Piulats, Aura Muntasell, Rodrigo Dienstmann, Núria López-Bigas, Abel González-Pérez

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Lung metastases share common immune features regardless of primary tumor origin

    Lung metastases share common immune features regardless of primary tumor origin por Sandra García‐Mulero, M. Henar Alonso, Julián Pardo, Cristina Santos, Xavier Sanjuán, Ramón Salazar, Vı́ctor Moreno, Josep M. Piulats, Rebeca Sanz‐Pamplona

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Dynamic Change of Polarity in Primary Cultured Spheroids of Human Colorectal Adenocarcinoma and Its Role in Metastasis

    Dynamic Change of Polarity in Primary Cultured Spheroids of Human Colorectal Adenocarcinoma and Its Role in Metastasis por Hiroaki Okuyama, Jumpei Kondo, Yumi Sato, Hiroko Endo, Aya Nakajima, Josep M. Piulats, Yasuhiko Tomita, Takeshi Fujiwara, Yu Itoh, Akira Mizoguchi, Masayuki Ohue, Masahiro Inoue

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Sunitinib Inhibits Tumor Growth and Synergizes with Cisplatin in Orthotopic Models of Cisplatin-Sensitive and Cisplatin-Resistant Human Testicular Germ Cell Tumors

    Sunitinib Inhibits Tumor Growth and Synergizes with Cisplatin in Orthotopic Models of Cisplatin-Sensitive and Cisplatin-Resistant Human Testicular Germ Cell Tumors por Wilmar Castillo, Josep M. Piulats, Xavier García del Muro, August Vidal, Enric Condom, Oriol Casanovas, Josefina Móra, Josep R. Germà, Gabriel Capellà, Alberto Villanueva, Francesc Viñals

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients

    A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients por Margarita García, Rafael Moreno, Marta Gil-Martín, Manel Cascalló, María Ochoa de Olza, C. Cuadra, Josep M. Piulats, Valentín Navarro, Marta Domènech, Ramón Alemany, Ramón Salazar

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    KEYNOTE-921: Phase III Study of Pembrolizumab Plus Docetaxel for Metastatic Castration-Resistant Prostate Cancer

    KEYNOTE-921: Phase III Study of Pembrolizumab Plus Docetaxel for Metastatic Castration-Resistant Prostate Cancer por Daniel P. Petrylak, Raffaele Ratta, Rustem Gafanov, Gaetano Facchini, Josep M. Piulats, Gero Kramer, Thomas W. Flaig, Sreenivasa R Chandana, Ben Li, Joseph E. Burgents, Karim Fizazi

    Publicado 2021
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Chemotherapy As an Alternative to Radiotherapy in the Treatment of Stage IIA and IIB Testicular Seminoma: A Spanish Germ Cell Cancer Group Study

    Chemotherapy As an Alternative to Radiotherapy in the Treatment of Stage IIA and IIB Testicular Seminoma: A Spanish Germ Cell Cancer Group Study por Xavier García del Muro, Pablo Maroto, Josep Gumà, Javier Sastre, Marta López Brea, José Ángel Arranz, Núria Laínez, Diego Soto de Prado, Jorge Aparicio, Josep M. Piulats, Xavier Pérez, Josep Ramón Germà-Lluch

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)

    Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629) por Jean‐Jacques Grob, René González, Nicole Basset‐Séguin, Olga Vornicova, Jacob Schachter, Abhishek Joshi, Nicolás Meyer, Florent Grange, Josep M. Piulats, Jessica R. Bauman, Pingye Zhang, Burak Gümüşçü, Ramona F. Swaby, Brett Hughes

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer

    Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer por Johann S. de Bono, Josep M. Piulats, Hardev Pandha, Daniel P. Petrylak, Fred Saad, Luis M. Antón Aparicio, Shahneen Sandhu, Peter C.C. Fong, Silke Gillessen, Gary R. Hudes, Tao Wang, J. R. Scranton, Michaël Pollak

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    A phase II study (AARDVARC) of AZD4635 in combination with durvalumab and cabazitaxel in patients with progressive, metastatic, castration-resistant prostate cancer

    A phase II study (AARDVARC) of AZD4635 in combination with durvalumab and cabazitaxel in patients with progressive, metastatic, castration-resistant prostate cancer por Teresa Alonso‐Gordoa, Michael Goodman, Christof Vulsteke, Guilhem Roubaud, J. Zhang, Mamta Parikh, Josep M. Piulats, A. Ázaro, Gary D. James, Riccardo Cavazzina, Eric T. Gangl, Jeff Thompson, Gayle P. Pouliot, Rakesh Kumar, Christopher J. Sweeney

    Publicado 2024
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy

    AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy por Joan Anton Puig‐Butillé, Antònia Vinyals, J.R. Ferreres, Paula Aguilera, Eduard Cabré, Gemma Tell‐Martí, Joaquim Marcoval, Francesca Mateo, Luís Palomero, Célia Bádenas, Josep M. Piulats, Josep Malvehy, Miguel Ángel Pujana, Susana Puig, Àngels Fabra

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Sensitivity of cervico‐vaginal cytology in endometrial carcinoma: A systematic review and meta‐analysis

    Sensitivity of cervico‐vaginal cytology in endometrial carcinoma: A systematic review and meta‐analysis por Jon Frias‐Gomez, Yolanda Benavente, Jordi Ponce, Joan Brunet, Raquel Ibáñez, Paula Peremiquel‐Trillas, Núria Baixeras, Alba Zanca, Josep M. Piulats, Àlvaro Aytés, Xavier Matías‐Guiu, F. Xavier Bosch, Sílvia de Sanjosé, Laia Alemany, Laura Costas

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  16. 16
    Epigenetic disruption of cadherin‐11 in human cancer metastasis

    Epigenetic disruption of cadherin‐11 in human cancer metastasis por F. Javier Carmona, Alberto Villanueva, August Vidal, Clara Muñoz, Sara Puertas, R.M. Penín, Montserrat Gomà‐i‐Freixanet, Amaia Lujambio, Josep M. Piulats, Ricard Mesı́a, Montse Sánchez‐Céspedes, M. Mañós, Enric Condom, Suzanne A. Eccles, Manel Esteller

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    1,4-dihydroxy quininib activates ferroptosis pathways in metastatic uveal melanoma and reveals a novel prognostic biomarker signature

    1,4-dihydroxy quininib activates ferroptosis pathways in metastatic uveal melanoma and reveals a novel prognostic biomarker signature por Valentina Tonelotto, Marcel Costa-García, Eve O’Reilly, Kaelin Francis Smith, Kayleigh Slater, Eugène Dillon, Marzia Pendino, Catherine Higgins, Paola Sist, Rosa Bosch, Sabina Passamonti, Josep M. Piulats, Alberto Villanueva, Federica Tramer, Luca Vanella, Michelle Carey, Breandán N. Kennedy

    Publicado 2024
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    ERA 223: A phase III trial of radium-223 (Ra-223) in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve patients (pts) with bone-predominant metastatic castration-resistant prostate cancer (mCRPC)

    ERA 223: A phase III trial of radium-223 (Ra-223) in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mildly symptomatic chemot... por Mitchell R. Smith, Chris Parker, Fred Saad, K. Miller, Bertrand Tombal, Quan Sing Ng, Martin Bögemann, В. Б. Матвеев, Josep M. Piulats, Luis Eduardo Rosa Zucca, Axel Heidenreich, Yoshiyuki Kakehi, A. Zhang, Heiko Krissel, Jiayu Shen, V. Wagner, Celestia S. Higano

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)

    Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402) por Josep M. Piulats, Enrique Espinosa, Luis de la Cruz‐Merino, Mar Varela, Lorenzo Alonso-Carrión, Salvador Martín‐Algarra, Rafael López Castro, Teresa Curiel, Delvys Rodríguez‐Abreu, Miriam Redrado, Montserrat Gomà‐i‐Freixanet, Antonio Rullan, Alfonso Calvo González, Alfonso Berrocal-Jaime

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis

    Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis por Josep M. Piulats, Claire Watkins, Marcel Costa-García, L. Del Carpio, Sophie Piperno‐Neumann, Piotr Rutkowski, Jessica C. Hassel, Enrique Espinosa, Luis de la Cruz‐Merino, Sebastian Ochsenreither, A.N. Shoushtari, Marlana Orloff, April K.S. Salama, Howard Goodall, Jean‐François Baurain, Paul Nathan

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: